Table 2.
Changes in Fatigue and Blood Parametersa.
| NC (n = 7) | EX (n = 8) |
CON (n = 7) |
|||
|---|---|---|---|---|---|
| Pre | Post | Pre | Post | ||
| Fatigue parameters | |||||
| Total | 1.0 ± 1.0b | 5.0 ± 2.2 | 2.6 ± 1.9c | 4.7 ± 2.5 | 3.2 ± 2.4 |
| Behavioral | 0.9 ± 1.3b | 4.5 ± 3.0 | 1.9 ± 2.2c | 4.2 ± 3.5 | 3.0 ± 3.1 |
| Affective | 0.7 ± 0.8b | 5.7 ± 2.5 | 2.3 ± 2.4c | 5.2 ± 2.5 | 3.6 ± 2.5 |
| Sensory | 1.4 ± 1.3b | 5.9 ± 2.2 | 3.4 ± 2.3c | 5.0 ± 2.4 | 3.5 ± 2.3 |
| Cognitive | 1.2 ± 1.2b | 4.5 ± 2.3 | 2.7 ± 1.8c | 5.0 ± 2.0 | 2.9 ± 2.1c |
| Blood parameters | |||||
| TEAC | 1.0 ± 0.20b | 0.75 ± 0.19 | 1.06 ± 0.13c | 0.69 ± 0.16 | 0.85 ± 0.22 |
| Protein carbonyls | 1.0 ± 0.28b | 1.46 ± 0.49 | 0.94 ± 0.37c | 1.32 ± 0.48 | 1.26 ± 0.25 |
| 8-OHdG | 1.0 ± 0.57 | 1.45 ± 0.96 | 0.88 ± 0.55d | 1.08 ± 0.44 | 1.48 ± 0.66 |
Abbreviations: NC, noncancer baseline control group; EX, exercise cancer group; CON, cancer control group; TEAC, Trolox-equivalent antioxidant capacity.
a
Data are presented as mean ± SD. Blood parameters expressed as arbitrary units (% of baseline control).
b
Significantly different than cancer patients at baseline (P < .05).
c
Significant change from baseline (P < .05).
d
Significant time by group interaction with control group (P < .05).